Industries > Life Sciences & Healthcare > Health Economics & Outcomes Research

Health Economics & Outcomes Research

SG Analytics (SGA) uses AI/ML algorithms to provide exact answers when assessing the value of a new treatment or product for reimbursements and healthcare payers.

Blogs | The Power of Data Visualization in the UK's Healthcare Sector

HEOR Services: Health Economic Outcomes Research

Daily and favorable health outcomes are analyzed through HEOR studies of healthcare providers, clinics, hospitals, managed care, and community health promotion initiatives in various settings.  In 2020, SG Analytics first offered HEOR services and solutions. Our pharmaceutical clients consistently rank this service among our most in-demand options. Using ML technologies, our health economics and outcomes research experts can scrape accurate real-world data relevant to medical research and disease areas, transforming a time-consuming procedure into a straightforward, white-labeled, unique report.  Read More
Health economics outcomes research services

Why SGA

Industry Leaders

SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.

12+ Languages

Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).

Data-Driven Insights

With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.

End-To-End Solutioning

The in-house KOL capability of more than 700, along with in-house capabilities of primary market research, financial research, data analytics, engineering, IT, and ESG research and consulting, helps to present credible competitive information.

Who We Work With

Insights

SG Analytics - Healthcare - Whitepaper - Emergence of Novel Immune-Mediated Therapies

Whitepapers

Emergence of Novel Immune - Mediated Therapies

Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to...

Technological  Advancements

Whitepapers

Future Trends and Technological Advances in Vaccine and Disease Prevention

The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...

SGA Whitepaper Market Entry in 2023

Whitepapers

Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?

Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...

We strongly believe in equal opportunity for all. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.

Our combined experience of pharmaceuticals, medical devices, life sciences, and med-tech ensures high-quality, white-labelled research coverage.